-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.
-
Summary
-
Tvardi Therapeutics, Inc. quarterly/annual Current Income Tax Expense (Benefit) history and change rate from 2012 to Q3 2025.
- Tvardi Therapeutics, Inc. Current Income Tax Expense (Benefit) for the quarter ending 30 Sep 2025 was $0.000.
- Tvardi Therapeutics, Inc. annual Current Income Tax Expense (Benefit) for 2024 was -$398K.
- Tvardi Therapeutics, Inc. annual Current Income Tax Expense (Benefit) for 2020 was -$691K, a 15.3% increase from 2019.
- Tvardi Therapeutics, Inc. annual Current Income Tax Expense (Benefit) for 2019 was -$816K, a 110% decline from 2018.
Current Income Tax Expense (Benefit), Quarterly (USD)
Current Income Tax Expense (Benefit), Annual (USD)
Current Income Tax Expense (Benefit), YoY Annual Change (%)